Knowles Julius - Insider Non-Derivative Transactions at Keros Therapeutics, Inc. (KROS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 21, 2025, Knowles Julius's relationship to Keros Therapeutics, Inc. (KROS) is Director, and currently has 150,047 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KROS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Knowles Julius - Insider Non-Derivative Transactions of KROS Common Stock

Knowles Julius - Insider Non-Derivative Transactions at KROS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 22, 2025	Disposition -- (Common Stock)	130494	17.75	102233
Nov 22, 2025	Disposition -- (Common Stock)	191527	17.75	150047
Jun 5, 2025	Acquisition -- (Common Stock)	5250	0	6441
Apr 14, 2020	P -- (Common Stock)	1191	20.98	1191